BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

This study has been suspended.

( protocol development and Amended protocol revision )

Study NCT00077493 Information provided by MedImmune LLC

First Received: February 10, 2004 Last Updated: December 21, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	October 2008
Estimated Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)